|
|
Volumn 25, Issue 1, 2007, Pages 1-2
|
|
On the road to new drugs in acute myeloid leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CLORETAZINE;
CYTARABINE;
DAUNORUBICIN;
HYDRAZINE DERIVATIVE;
IDARUBICIN;
MITOXANTRONE;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN FARNESYLTRANSFERASE INHIBITOR;
TROXACITABINE;
UNCLASSIFIED DRUG;
VASCULOTROPIN INHIBITOR;
VNP 40101M;
ACUTE GRANULOCYTIC LEUKEMIA;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER RELAPSE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CYTOGENETICS;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
MOLECULAR BIOLOGY;
PREDICTION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
CHEMISTRY;
DRUG DESIGN;
METHODOLOGY;
NOTE;
REMISSION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMISTRY, PHARMACEUTICAL;
CLINICAL TRIALS;
DRUG DESIGN;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
REMISSION INDUCTION;
TREATMENT OUTCOME;
|
|
EID: 34548488183
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.08.6462 Document Type: Editorial |
|
Times cited : (4)
|
|
References (2)
|
